Keyword: Mannkind

Longtime Catalent CFO joins Allergan, Arcturus board and ousted CEO exchange fire, Lilly diabetes executive jumps to MannKind.

MannKind and One Drop are launching a study to gauge whether pairing the former's inhaled insulin with the latter's digital diabetes care platform will improve outcomes.

Lilly's longtime CFO Rice will retire, Akari's CEO resigned amid a false data scandal, MannKind replaced its CEO with the hope to revive Afrezza.